News

Filter

1 to 9 of 95934 results

BTG and SciClone's DC Bead liver cancer therapy approved in China

BTG and SciClone's DC Bead liver cancer therapy approved in China

28-08-2014

UK specialist health care company BTG and its partner, China-focused US specialty drugmaker SciClone…

BTGChinaDC BeadHepatologyOncologyPharmaceuticalSciClone PharmaSciClone Pharmaceuticals

Analysis of Roche’s InterMune acquisition

Analysis of Roche’s InterMune acquisition

28-08-2014

The acquisition of InterMune gives Swiss drug major Roche a substantial opportunity, owing to the Breakthrough…

BiotechnologyIdiopathic pulmonary fibrosisInterMuneMergers & AcquisitionspirfenidonePulmozymeRespiratory and PulmonaryRocheSwitzerlandXolair

Prescribing habits for biosimilars will depend on robust clinical trials and manufacturer reputation

Prescribing habits for biosimilars will depend on robust clinical trials and manufacturer reputation

28-08-2014

Physicians across six different specialties expect that they will base prescribing decisions for biosimilars…

BiosimilarsBiotechnologyDecision Resources GroupMarkets & Marketing

UK NICE wants more info on type 2 diabetes drug Jardiance

UK NICE wants more info on type 2 diabetes drug Jardiance

28-08-2014

In a new draft guidance issued today, the UK drugs watchdog the National Institute for Health and Care…

Boehringer IngelheimDiabetesEli LillyJardiancePharmaceuticalPricingRegulationUK

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending

28-08-2014

With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

Bristol-Myers’ hep C drug Daklinza approved in Europe

Bristol-Myers’ hep C drug Daklinza approved in Europe

27-08-2014

US pharma major Bristol-Myers Squibb says that the European Commission has approved Daklinza (daclatasvir),…

Anti-viralsBristol-Myers SquibbDaklinzaEuropeGilead SciencesPharmaceuticalRegulationSovaldi

FDA priority review for Amgen’s ivabradine in CHF

FDA priority review for Amgen’s ivabradine in CHF

27-08-2014

The US Food and Drug Administration has granted priority review designation for US biotech giant Amgen’s…

AmgenBiotechnologyCardio-vascularivabradineRegulationServierUSA

1 to 9 of 95934 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top